Myhep Lvir Ledipasvir And Sofosbuvir Tablets ₹ 4999 / Bottle Get Latest Price Product Brochure Strength 90mg/400mg Quantity Per Pack 28 Tabs Manufactured By MYLAN PHARMACEUTICALS PVT LTD Item Name Myhep Lvir Trade Name Myhep Lvir Usage Chronic Hepatitis C virus infection. Country of Origin Made in India Myhep Lvir Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection. This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Myhep Lvir Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment. Talk to your doctor immediately before taking this drug if you have diabetes. You may need closer monitoring of your blood glucose levels or adjustment of your diabetes medication after starting this drug. Some diabetic patients have experienced low sugar levels in the blood (hypoglycemia) after starting treatment with medicines like Myhep Lvir Tablet. The doctor will test your blood before, during, and after your treatment with this medicine. So that your doctor can confirm that your treatment has worked and you are free of the hepatitis C virus, do not breastfeed during treatment with this tablet. It is unknown whether this drug passes into human breast milk. Consult your doctor if you are breastfeeding. Do not give this tablet to children under three years of age. The use of this drug has not yet been studied. This tablet can interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions. Uses of Myhep Lvir Tablet Chronic Hepatitis C virus infection

HQTOR 200 MG 100 TAB TORRENT PHARMACEUTICALS LTD ₹ 200 / Stripe Get Latest Price Product Brochure Strength 200 mg Composition Hydroxycholo sulphate Packaging Type Stripe Packaging Size 10*10 Tablets Prescription/Non prescription Prescription Brand HQTOR 200 MG Form Tablet Usage / Application Personal Country of Origin Made in India Minimum order quantity: 10 Stripe We are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our

ivermectin for humans 12mg Tablet ₹ 50 / Stripe Get Latest Price Strength 12mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.

iveremectin Ivecop 6 Mg Tablet ₹ 35 / Stripe Get Latest Price Strength 6mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.

NOOTROPIL 1200MG 10 TAB PIRACETAM Get Best Quote ₹ 290 / Box Get Latest Price Packaging Size 10*10 Brand NOOTROPIL 1200MG Prescription/Non prescription Prescription Shelf life 24 months Country of Origin Made in India Minimum order quantity: 10 Box We are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our client

Nervisign 300mg Tablet ₹ 180 / Stripe Get Latest Price Strength 300 mg Dose/Strength 300 mg Packaging Size 1x30Tablets Packaging Type Strip Shelf Life 24 Months Usage / Application Personal Country of Origin Made in India We Are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our client

PHENERGAN 25MG 500 TAB PROMETHAZINE HCL ₹ 45 / Stripe Get Latest Price Strength 25 mg Usage/Application Personal Generic Name PHENERGAN Dosage Form Tablet Brand PHENERGAN Packaging Size 50*10 Country of Origin Made in India Minimum order quantity: 10 Stripe We Are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our client

MYSOLINE 250MG 300 TAB PRIMIDONE ₹ 120 / Box Get Latest Price Strength 250 mg Brand Name MYSOLINE 250MG Packaging Size 10*10 Tablets Packaging Type Strips Brand MYSOLINE Country of Origin Made in India Minimum order quantity: 10 Box We are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our client

LEVEPSY XR 750MG 150 TAB LEVETIRACETAM ER ₹ 155 / Stripe Get Latest Price Strength 750 mg Packaging Size 10*10 Prescription/Non prescription Prescription Manufactured By Cipla Country of Origin Made in India Minimum order quantity: 10 Stripe We Are engaged in Offering Pharmaceutical Medicines in wide segment like anti diabetic Asthama anti cancer Anti HIV Dermal Pain Killer Weight management medicines with supply of Quality Products to our Clients our Range of Products are really appreciated by our client